Chlorthalidone is a long-acting diuretic used to treat high blood pressure, and its most significant long-term side effects involve electrolyte imbalances, metabolic changes, and sexual dysfunction. Most of these effects are manageable with routine blood work and dose adjustments, but they’re worth understanding if you’re taking this medication for months or years.
Low Potassium and Sodium
The most well-known long-term concern with chlorthalidone is hypokalemia, or low potassium. Because the drug works by making your kidneys excrete more water and salt, potassium gets flushed out along with it. In large database studies, about 6.3% of patients on chlorthalidone developed low potassium, compared to just 1.9% on a similar diuretic, hydrochlorothiazide. That’s more than three times the rate, which reflects chlorthalidone’s longer duration of action in the body.
Low potassium can cause muscle cramps, weakness, fatigue, and in more serious cases, irregular heart rhythms. Chlorthalidone also raises the risk of low sodium (hyponatremia) by about 31% compared to hydrochlorothiazide. Low sodium can show up as confusion, headaches, nausea, or unsteadiness, especially in older adults. Both of these electrolyte shifts can begin within days of starting the medication, which is why periodic blood tests are part of the routine when you’re on it.
Adding a potassium-sparing agent can minimize or prevent the potassium drop. Eating potassium-rich foods like bananas, potatoes, and leafy greens helps too, though dietary changes alone aren’t always enough to offset the loss.
Blood Sugar and Diabetes Risk
Chlorthalidone can nudge your blood sugar levels upward over time. In the landmark ALLHAT trial, which followed thousands of patients, 11.6% of those taking chlorthalidone developed new-onset diabetes over four years. That compares to 9.8% for a calcium channel blocker and 8.1% for an ACE inhibitor. So the absolute increase in risk is real but modest.
The actual change in fasting blood sugar is small in most people. The average difference between chlorthalidone and an ACE inhibitor in the same trial was less than 5 mg/dL. For context, that’s a shift most people wouldn’t notice on a lab report. Still, if you already have prediabetes or other risk factors for type 2 diabetes, this is something worth tracking. Your blood sugar and lipid levels should be monitored periodically while you’re on the drug.
Uric Acid and Gout
Chlorthalidone tends to raise uric acid levels in the blood. When uric acid builds up, it can crystallize in joints and trigger gout, a form of intensely painful arthritis that most often hits the big toe. In one five-year study of nearly 3,700 participants, actual gout episodes were uncommon (only 15 recorded), but the risk is higher if you’ve had gout before. Among people with a history of gout, any diuretic use roughly tripled the odds of a recurrent flare within 48 hours of taking it.
If you’ve never had gout, chlorthalidone probably won’t cause it. But if you have a history of gout or elevated uric acid, this side effect deserves a conversation with your prescriber about whether a different blood pressure medication might be a better fit.
Erectile Dysfunction
Sexual side effects are an underappreciated concern. In the Treatment of Mild Hypertension Study (TOMHS), 17.1% of men taking chlorthalidone reported erection problems within the first two years, compared to 8.1% of men on placebo. That’s roughly double the rate. Other blood pressure medications in the same trial, including ACE inhibitors and calcium channel blockers, did not significantly differ from placebo.
There’s a silver lining in the data, though. After the first two years, the gap between chlorthalidone and placebo narrowed, and new cases of erectile dysfunction after that point were unlikely. The effect appears to hit early and then stabilize. For women in the study, sexual side effects were low across all groups and didn’t differ by medication type.
Kidney Function Changes
Because chlorthalidone changes how your kidneys handle water and electrolytes, it can cause a mild rise in creatinine, a waste product that reflects how well your kidneys are filtering. In an eight-week study of patients with already reduced kidney function, creatinine increased by about 0.07 to 0.14 mg/dL from baseline. That kind of small bump is expected and typically not a sign of kidney damage.
A more concerning signal would be a doubling of your baseline creatinine, which is the threshold researchers use to define acute kidney injury. This is rare but possible, particularly in people who are dehydrated or taking other medications that stress the kidneys. Periodic kidney function tests help catch any problems early.
How It Compares to Hydrochlorothiazide
Chlorthalidone and hydrochlorothiazide (HCTZ) are both thiazide-type diuretics, but they aren’t interchangeable when it comes to side effects. Chlorthalidone lasts longer in the body and lowers blood pressure more effectively around the clock, but that same potency comes with a trade-off. A large comparative study in JAMA Internal Medicine found that chlorthalidone carried higher rates of hypokalemia (6.3% vs. 1.9%) and a 31% greater risk of hyponatremia compared to HCTZ. Electrolyte imbalances can start almost immediately, with the risk window beginning as early as one day after the first dose.
The metabolic effects, including blood sugar and uric acid changes, are generally similar between the two drugs, though chlorthalidone’s longer half-life means its effects are more sustained. If side effects from chlorthalidone are difficult to manage, switching to HCTZ is one option your prescriber might consider.
What Monitoring Looks Like
The FDA’s prescribing information for chlorthalidone calls for periodic monitoring of several lab values: kidney function, electrolytes (potassium, sodium, and calcium), blood sugar, and lipid levels. In practice, this typically means blood work shortly after starting the drug, then at regular intervals as long as you’re taking it. If your potassium runs low, your prescriber may add a potassium-sparing medication or adjust your dose rather than stopping chlorthalidone entirely.
Calcium levels also deserve attention. Chlorthalidone can cause the body to retain calcium, which is actually protective against kidney stones but can be a problem if your calcium is already elevated. If you have a condition that raises calcium levels, such as overactive parathyroid glands, this needs to be monitored more closely.